-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Q4 EPS Estimate for Corcept Therapeutics Lifted by Analyst
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Equities researchers at HC Wainwright increased their Q4 2025 earnings estimates for shares of Corcept Therapeutics in a report issued on Thursday, February 27th. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology company will post earnings of $0.73 per share for the quarter, up from […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Equities researchers at HC Wainwright increased their Q4 2025 earnings estimates for shares of Corcept Therapeutics in a report issued on Thursday, February 27th. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology company will post earnings of $0.73 per share for the quarter, up from […]
